S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:ALGN

Align Technology Stock Forecast, Price & News

$619.75
-5.18 (-0.83%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$605.49
$632.57
50-Day Range
$589.61
$711.02
52-Week Range
$494.45
$737.45
Volume
536,100 shs
Average Volume
596,391 shs
Market Capitalization
$48.87 billion
P/E Ratio
66.64
Dividend Yield
N/A
Beta
1.57
30 days | 90 days | 365 days | Advanced Chart
Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.


Align Technology logo

About Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and vivera retainers for treating malocclusion. The Scanner and Services segment comprises of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Headlines

Gabriel Plotkin’s Melvin Capital Portfolio: Top 10 Picks
November 11, 2021 |  finance.yahoo.com
This Underrated Healthcare Stock Could Make You Richer
November 11, 2021 |  finance.yahoo.com
Notable Align Tech Insider Makes $2.1M Sale
November 10, 2021 |  finance.yahoo.com
Why Align Technology Stock Just Popped
October 28, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ALGN
CUSIP
01625510
Employees
18,070
Year Founded
1997

Sales & Book Value

Annual Sales
$2.47 billion
Cash Flow
$23.51 per share
Book Value
$44.60 per share

Profitability

Net Income
$1.78 billion
Pretax Margin
26.81%

Debt

Price-To-Earnings

Miscellaneous

Free Float
78,301,000
Market Cap
$48.87 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/26/2021
Today
12/06/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/02/2022

Social Links


MarketRank

Overall MarketRank

2.33 out of 5 stars

Medical Sector

265th out of 1,388 stocks

Surgical Appliances & Supplies Industry

8th out of 27 stocks

Analyst Opinion: 2.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Align Technology (NASDAQ:ALGN) Frequently Asked Questions

Is Align Technology a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Align Technology stock.
View analyst ratings for Align Technology
or view top-rated stocks.

How has Align Technology's stock been impacted by COVID-19?

Align Technology's stock was trading at $202.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALGN shares have increased by 206.5% and is now trading at $619.75.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Align Technology?

Align Technology saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,550,000 shares, an increase of 24.0% from the October 31st total of 1,250,000 shares. Based on an average daily volume of 590,400 shares, the short-interest ratio is currently 2.6 days. Currently, 2.1% of the company's stock are short sold.
View Align Technology's Short Interest
.

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Align Technology
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) issued its earnings results on Tuesday, October, 26th. The medical equipment provider reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $0.27. The medical equipment provider had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $977.81 million. Align Technology had a net margin of 19.70% and a trailing twelve-month return on equity of 21.88%. The firm's quarterly revenue was up 38.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.76 EPS.
View Align Technology's earnings history
.

What guidance has Align Technology issued on next quarter's earnings?

Align Technology issued an update on its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.90 billion-$3.95 billion, compared to the consensus revenue estimate of $3.94 billion.

What price target have analysts set for ALGN?

13 Wall Street analysts have issued 1-year price objectives for Align Technology's shares. Their forecasts range from $555.00 to $825.00. On average, they expect Align Technology's share price to reach $735.83 in the next year. This suggests a possible upside of 18.7% from the stock's current price.
View analysts' price targets for Align Technology
or view top-rated stocks among Wall Street analysts.

Who are Align Technology's key executives?

Align Technology's management team includes the following people:
  • Joseph M. Hogan, President, Chief Executive Officer & Director
  • Emory M. Wright, Senior Vice President-Global Operations (LinkedIn Profile)
  • John F. Morici, Chief Financial Officer & SVP-Global Finance (LinkedIn Profile)
  • Zelko Relic, Chief Technology Officer & Senior Vice President
  • Jennifer Olson, SVP & MD, Doctor-Directed Consumer Channel

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology CEO Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among Align Technology's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), salesforce.com (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.00%), Edgewood Management LLC (5.68%), Sands Capital Management LLC (3.68%), Wellington Management Group LLP (2.72%), Janus Henderson Group PLC (2.66%) and Alliancebernstein L.P. (2.22%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Kevin C Burns, Robert E Fitzgerald, Simon Beard, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends for Align Technology
.

Which major investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Invesco Ltd., Citigroup Inc., Polar Capital Holdings Plc, Morgan Stanley, Bank of New York Mellon Corp, Deutsche Bank AG, and Assenagon Asset Management S.A.. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Julie Ann Coletti, Kevin C Burns, Stuart A Hockridge, Thomas M Prescott, and Warren S Thaler.
View insider buying and selling activity for Align Technology
or view top insider-selling stocks.

Which major investors are buying Align Technology stock?

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Janus Henderson Group PLC, Wellington Management Group LLP, Arrowstreet Capital Limited Partnership, Los Angeles Capital Management LLC, Alliancebernstein L.P., Nordea Investment Management AB, and Manning & Napier Group LLC.
View insider buying and selling activity for Align Technology
or or view top insider-buying stocks.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $619.75.

How much money does Align Technology make?

Align Technology has a market capitalization of $48.87 billion and generates $2.47 billion in revenue each year. The medical equipment provider earns $1.78 billion in net income (profit) each year or $9.30 on an earnings per share basis.

How many employees does Align Technology have?

Align Technology employs 18,070 workers across the globe.

When was Align Technology founded?

Align Technology was founded in 1997.

What is Align Technology's official website?

The official website for Align Technology is www.aligntech.com.

Where are Align Technology's headquarters?

Align Technology is headquartered at 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at (408) 470-1000, via email at [email protected], or via fax at 408-470-1010.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.